Stockscreener 앱 받기
5.69
4.53%
-0.27
시간 외 거래:
5.55
-0.14
-2.46%
전일 마감가:
$5.96
열려 있는:
$5.74
하루 거래량:
323.74K
Relative Volume:
1.25
시가총액:
$119.64M
수익:
-
순이익/손실:
$-52.07M
주가수익비율:
-27.40
EPS:
-0.2077
순현금흐름:
$-44.93M
1주 성능:
-15.33%
1개월 성능:
-23.73%
6개월 성능:
-38.49%
1년 성능:
-64.68%
1일 변동 폭
$5.50
$5.84
1주일 범위
$5.50
$6.6392
52주 변동 폭
$5.50
$16.55
Cybin Inc Stock (CYBN) Company Profile
명칭
Cybin Inc
전화
908 764 8385
주소
100 King Street West, Suite 5600, Toronto
CYBN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYBN
Cybin Inc
|
5.69 | 119.64M | 0 | -52.07M | -44.93M | -0.2077 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Guggenheim | Buy |
| 2021-11-19 | 다운그레이드 | Maxim Group | Buy → Hold |
Cybin Inc 주식(CYBN)의 최신 뉴스
4 Psychedelic Stocks to Buy Now - The Motley Fool
Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th - Business Wire
(CYBN) Investment Analysis and Advice - news.stocktradersdaily.com
Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation - Nasdaq
Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - Seeking Alpha
Cybin initiated with a Buy at Guggenheim - TipRanks
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress - TipRanks
Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership - GlobeNewswire Inc.
Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq
Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN
Cybin (OTCMKTS:CLXPF) Shares Down 2.5%Here's What Happened - MarketBeat
How to Take Advantage of moves in (CYBN) - news.stocktradersdaily.com
Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor
Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat
Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat
Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN
Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat
Cybin stock price target cut to $150 at H.C. Wainwright - MSN
Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia
Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria
(CYBN) Investment Analysis - Stock Traders Daily
Cybin sees third-quarter loss on R&D costs, advances clinical programs - Green Market Report
Cybin Accelerates PARADIGM Program for Depression Treatment - TipRanks
Cybin's Depression Drug Shows Perfect Response Rate, Advances to Pivotal Phase 3 with C$136M War Chest - StockTitan
Upstart (UPST) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
Trade thoughts for Gold futures - The Globe and Mail
Is Rigetti Computing a Millionaire-Maker Stock? - The Globe and Mail
HC Wainwright Forecasts Cybin's Q3 Earnings (NYSE:CYBN) - MarketBeat
What is HC Wainwright's Estimate for Cybin FY2029 Earnings? - MarketBeat
Cybin (OTCMKTS:CLXPF) Shares Up 1.9%What's Next? - MarketBeat
What is HC Wainwright's Forecast for Cybin FY2029 Earnings? - MarketBeat
How To Trade (CYBN) - Stock Traders Daily
Cybin Inc (CYBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):